These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3488025

  • 1. [The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].
    Hanaue H, Kurosawa T, Miyakawa S, Kitano Y, Nemoto A, Yamoto H, Asagoe T, Shikata J.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1285-9. PubMed ID: 3488025
    [Abstract] [Full Text] [Related]

  • 2. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
    Hanaue H, Kim DY, Kubota M, Kurosawa T, Shikata J, Kondoh Y, Ogoshi K, Makuuchi H, Nakasaki H, Mitomi T.
    Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytes.
    Hanaue H, Kim DY, Machimura T, Tsukui M, Kubota M, Kurosawa T, Shikata J, Kondoh Y, Ogoshi K, Makuuchi H.
    Tokai J Exp Clin Med; 1987 Sep; 12(3):159-65. PubMed ID: 3502615
    [Abstract] [Full Text] [Related]

  • 4. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
    Takada T, Yasuda H, Uchiyama K, Hasegawa H, Miura S, Asagoe T, Hanaue H, Shikata J.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2305-13. PubMed ID: 2934024
    [Abstract] [Full Text] [Related]

  • 5. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 6. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
    Hanaue H, Kurosawa T, Nemoto A, Asagoe T, Shikata J.
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug 20; 22(7):1348-53. PubMed ID: 3501454
    [No Abstract] [Full Text] [Related]

  • 7. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].
    Hosoi J.
    Nihon Gan Chiryo Gakkai Shi; 1987 Apr 20; 22(3):603-13. PubMed ID: 2443588
    [No Abstract] [Full Text] [Related]

  • 8. [Immunological study on localized liver injection of immunopotentiator OK-432-- experimental studies in rats].
    Takada T, Yasuda H, Uchiyama K, Hasegawa H.
    Gan To Kagaku Ryoho; 1984 Oct 20; 11(10):2267-71. PubMed ID: 6333213
    [Abstract] [Full Text] [Related]

  • 9. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
    Hanaue H, Kurosawa T, Kitano Y, Miyagawa S, Nemoto A, Yamato H, Asagoe T, Shikata J.
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug 20; 22(7):1367-72. PubMed ID: 3501455
    [No Abstract] [Full Text] [Related]

  • 10. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H, Nomoto S, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Keio J Med; 1982 Dec 20; 31(4):159-68. PubMed ID: 6985379
    [No Abstract] [Full Text] [Related]

  • 11. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G.
    Nihon Geka Gakkai Zasshi; 1990 Jan 20; 91(1):68-76. PubMed ID: 2314383
    [Abstract] [Full Text] [Related]

  • 12. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H, Kikkawa H, Bando H, Sakatoku M, Hirano M, Tatsuzawa T.
    Gan No Rinsho; 1988 Nov 20; 34(14):1965-8. PubMed ID: 3204664
    [Abstract] [Full Text] [Related]

  • 13. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M.
    Nihon Geka Gakkai Zasshi; 1988 Jun 20; 89(6):880-8. PubMed ID: 2972906
    [Abstract] [Full Text] [Related]

  • 14. [Immunotherapy, with OK-432 for cases of nasopharyngeal carcinoma].
    Tsukuda M, Tamamushi N, Mochimatsu I, Mitarai K, Kaneko M, Sawaki S.
    Gan To Kagaku Ryoho; 1986 Jan 20; 13(1):53-9. PubMed ID: 3942399
    [Abstract] [Full Text] [Related]

  • 15. [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].
    Sekizuka H, Noro K, Haruyama S, Kiribuchi Y, Hayashi F.
    Gan No Rinsho; 1985 Sep 20; 31(11):1381-6. PubMed ID: 3877822
    [Abstract] [Full Text] [Related]

  • 16. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
    Sun CF, Hsieh YY, Ngan KW, Wang WT.
    Ann Clin Lab Sci; 2001 Apr 20; 31(2):171-8. PubMed ID: 11337907
    [Abstract] [Full Text] [Related]

  • 17. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):930-4. PubMed ID: 6721507
    [Abstract] [Full Text] [Related]

  • 18. [Subpopulations of T and B lymphocytes in venous peripheral blood and blood draining from lesions in patients with gastroduodenal ulcer, and gastric and colonic cancer].
    Rachel F, Rogozińska-Myśliwiec A.
    Wiad Lek; 1993 Jun 20; 46(11-12):433-40. PubMed ID: 8116293
    [Abstract] [Full Text] [Related]

  • 19. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M, Yamamoto H, Mizoguchi T, Hidaka K, Hisatsugu T, Torisu M.
    Gan To Kagaku Ryoho; 1987 Aug 20; 14(8):2464-8. PubMed ID: 3497612
    [Abstract] [Full Text] [Related]

  • 20. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients].
    Ochiai T, Sato H, Isono K, Uematsu T, Nakajima K, Mukai M, Asano T, Onoda S, Morioka Y, Danno M.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 1):959-69. PubMed ID: 3963860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.